Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,139Revenue (TTM) $M175Net Margin (%)14.9Altman Z-Score9.0
Enterprise Value $M1,118EPS (TTM) $0.5Operating Margin %15.4Piotroski F-Score5
P/E(ttm)50.4Beneish M-Score-1.7Pre-tax Margin (%)15.6Higher ROA y-yN
Price/Book8.310-y EBITDA Growth Rate %--Quick Ratio1.5Cash flow > EarningsY
Price/Sales7.05-y EBITDA Growth Rate %--Current Ratio1.7Lower Leverage y-yY
Price/Free Cash Flow43.0y-y EBITDA Growth Rate %-26.9ROA % (ttm)14.1Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)21.8Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M49.5ROIC % (ttm)37.9Gross Margin Increase y-yN

Gurus Latest Trades with SUPN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SUPNRobert Bruce 2016-09-30 Reduce-0.35%$20.55 - $26.68
($22.63)
$ 23.002%Reduce -26.72%164,581
SUPNJoel Greenblatt 2016-09-30 Sold Out $20.55 - $26.68
($22.63)
$ 23.002%Sold Out0
SUPNJoel Greenblatt 2016-06-30 Reduce$15.12 - $20.37
($17.7)
$ 23.0030%Reduce -29.04%12,455
SUPNRobert Bruce 2016-03-31 Reduce-0.12%$10.13 - $15.65
($13.02)
$ 23.0077%Reduce -11.78%224,581
SUPNJoel Greenblatt 2016-03-31 Reduce$10.13 - $15.65
($13.02)
$ 23.0077%Reduce -48.08%17,552
SUPNRobert Bruce 2015-12-31 Reduce-0.57%$12.78 - $18.86
($15.48)
$ 23.0049%Reduce -35.48%254,581
SUPNJoel Greenblatt 2015-12-31 Reduce$12.78 - $18.86
($15.48)
$ 23.0049%Reduce -13.63%33,808
SUPNRobert Bruce 2015-09-30 Reduce-1.5%$13.62 - $21.26
($18.58)
$ 23.0024%Reduce -43.19%394,581
SUPNJoel Greenblatt 2015-09-30 Reduce-0.01%$13.62 - $21.26
($18.58)
$ 23.0024%Reduce -55.66%39,142
SUPNGeorge Soros 2015-06-30 Sold Out -0.01%$12.09 - $18.37
($14.2)
$ 23.0062%Sold Out0
SUPNJoel Greenblatt 2015-06-30 Add0.01%$12.09 - $18.37
($14.2)
$ 23.0062%Add 111.74%88,267
SUPNGeorge Soros 2015-03-31 Buy 0.01%$8.18 - $12.09
($9.45)
$ 23.00143%New holding107,308
SUPNJoel Greenblatt 2015-03-31 Buy $8.18 - $12.09
($9.45)
$ 23.00143%New holding41,686
SUPNRobert Bruce 2014-12-31 Add0.68%$7.49 - $9.49
($8.4)
$ 23.00174%Add 73.65%694,581
SUPNRobert Bruce 2014-09-30 Add0.73%$7.99 - $11.13
($8.98)
$ 23.00156%Add 300.00%400,000
SUPNRobert Bruce 2014-06-30 Buy 0.25%$7.32 - $10.85
($8.88)
$ 23.00159%New holding100,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SUPN is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


SUPN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
PATRICK GREGORY SVP, CFO 2016-09-16Sell2,000$25-8view
PATRICK GREGORY SVP, CFO 2016-07-14Sell3,395$224.55view
Bhatt Padmanabh P.Sr. VP of IP, CSO 2016-04-11Sell30,762$16.4939.48view
Bhatt Padmanabh P.Sr. VP of IP, CSO 2015-12-09Sell14,238$14.954.36view
BARRETT M JAMESDirector 2015-12-08Sell212,970$14.5657.97view
BARRETT M JAMESDirector 2015-11-25Sell16,179$16.3540.67view
BARRETT M JAMESDirector 2015-11-18Sell93,000$16.6138.47view
BARRETT M JAMESDirector 2015-11-16Sell119,650$16.2441.63view
Bhatt Padmanabh P.Sr. VP of IP, CSO 2015-11-04Sell5,000$19.915.58view
Schwabe Stefan K.F.Executive Vice President R&D 2015-07-28Sell2,350$21.28.49view

Quarterly/Annual Reports about SUPN:

News about SUPN:

Articles On GuruFocus.com
Robert Bruce new Buys Feb 16 2015 
Third Quarter Was Robert Bruce's Busiest in 2014 Nov 21 2014 
Supernus Pharmaceuticals Reports Insider Buys Mar 26 2013 

More From Other Websites
Hedge Funds Are Crazy About Supernus Pharmaceuticals Inc (SUPN) Dec 02 2016
ETFs with exposure to Supernus Pharmaceuticals, Inc. : November 29, 2016 Nov 29 2016
Top Ranked Income Stocks to Buy for November 28th Nov 28 2016
Supernus Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : SUPN-US :... Nov 28 2016
Why Earnings Season Could Be Great for Supernus (SUPN) Nov 21 2016
SUPERNUS PHARMACEUTICALS INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a... Nov 18 2016
Supernus Receives Nasdaq Non-Compliance Notice Nov 17 2016
Supernus Receives Nasdaq Non-Compliance Notice Nov 17 2016
ETFs with exposure to Supernus Pharmaceuticals, Inc. : November 16, 2016 Nov 16 2016
Supernus Pharmaceuticals, Inc.: Leads amongst peers with strong fundamentals Nov 15 2016
Supernus Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : SUPN-US :... Nov 15 2016
Supernus, Puma Among 5 Biotech Stock Winners, Losers Monday Nov 14 2016
Supernus Provides Business Update Nov 14 2016
Supernus Provides Business Update Nov 14 2016
SUPERNUS PHARMACEUTICALS INC Files SEC form 8-K, Non-Reliance on Previous Financials, Audits or... Nov 14 2016
Supernus to Host a Business Update Call Nov 11 2016
Supernus to Host a Business Update Call Nov 11 2016
Supernus to Present at Three November Healthcare Conferences Nov 07 2016
SUPERNUS PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Oct 14 2016
Supernus (SUPN) Reports Encouraging Data from ADHD Study Oct 13 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)